Skip to main content
Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
44.26
-0.45 (-1.01%)
At close: Dec 5, 2025, 4:00 PM EST
44.28
+0.02 (0.05%)
After-hours: Dec 5, 2025, 5:59 PM EST

Dianthus Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
 Sep '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.086.242.836.421.48
Revenue Growth (YoY)
-42.64%120.63%-55.96%334.76%-
Gross Profit
3.086.242.836.421.48
Selling, General & Admin
31.2324.9918.166.741.96
Research & Development
112.1683.1132.8429.3812.61
Operating Expenses
143.39108.15136.1214.56
Operating Income
-140.31-101.86-48.17-29.71-13.09
Interest & Investment Income
12.8217.374.761.150
Currency Exchange Gain (Loss)
-0.03-0.06-0.090.14-0.03
Other Non Operating Income (Expenses)
-0.95-0.55-0.06-0.05-
EBT Excluding Unusual Items
-128.47-85.12-43.56-28.48-13.11
Gain (Loss) on Sale of Investments
2.120.15---
Pretax Income
-126.35-84.97-43.56-28.48-13.11
Net Income
-126.35-84.97-43.56-28.48-13.11
Net Income to Common
-126.35-84.97-43.56-28.48-13.11
Shares Outstanding (Basic)
3633514
Shares Outstanding (Diluted)
3633514
Shares Change (YoY)
28.44%546.44%489.48%-78.17%-
EPS (Basic)
-3.49-2.55-8.45-32.57-3.27
EPS (Diluted)
-3.49-2.55-8.45-32.57-3.27
Free Cash Flow
-109.63-78.29-36.97-29.21-9.94
Free Cash Flow Per Share
-3.03-2.35-7.17-33.41-2.48
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
-4558.41%-1633.75%-1704.67%-462.91%-886.59%
Profit Margin
-4104.78%-1362.78%-1541.22%-443.76%-888.14%
Free Cash Flow Margin
-3561.63%-1255.57%-1308.24%-455.18%-673.24%
EBITDA
-140.2-101.77-48.11-29.68-
D&A For EBITDA
0.110.10.070.03-
EBIT
-140.31-101.86-48.17-29.71-13.09
Revenue as Reported
3.086.242.83--
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q